Discuss advances and challenges in the advancement of novel therapeutic cancer vaccines

Share Article

SMi's inaugural conference on Cancer Vaccines held on 19th & 20th September in London will provide attendees with a complete view of the cancer immunotherapy field, focusing on the discovery of new vaccines, developments in target identification and vaccine delivery strategies, this informative event will bring together key opinion leaders in the field to provide attendees with an in depth look into current advances in cancer vaccines.

SMi is pleased to confirm Dr. Oliver Wilbert, Senior Director Immunotherapies, Merck KGaA as a speaker at their upcoming Cancer Vaccines conference

Dr. Wilbert is the Global Clinical Development Leader of the Muc-1 Antigen Specific Cancer
Immunotherapy project STIMUVAX, currently in Phase III. He will be presenting on the current challenges in the cancer immunotherapeutics and will be discussing how best to overcome them by looking at past failures and success stories. This unique case-study presentation is not to be missed!

This event will act as a unique platform to hear from and discuss with key experts in the field on the key issues such as Engineering vaccine adjuvant formulations, Developing mRNA vaccines and Alphaviruses as vectors in cancer therapy. Attending will enable you to:

Consider novel combination therapies in cancer vaccine development
Understand effective process development strategies
Evaluate developments in cell based immunotherapeutics
Discover strategies to improve success and overcome current issues in clinical trials
Learn about clinical and regulatory design of immunotherapy programs
Hear from the industry on updates on the most recent successful candidates in Phase III
Develop monitoring immunotherapy outcomes
Network and learn from key opinion leaders from industry and academia

For more information visit http://www.smi-online.co.uk/cancervaccinesevent79.asp alternatively contact Fateja Begum on +44 0 207 827 6184 or email on fbegum (at) smi-online (dot) co (dot) uk

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dale Butler
SMi Group Ltd
0207 827 6044
Email >
Follow us on
Visit website